Covid Newscast

The Next-Generation Of Scientific Exploration And Research

Skip to content
  • Categories
    • Discovery
    • Clinical
    • Clinical Trials
    • Long Covid
    • Vaccines
    • Computing
    • Pandemic
    • Antibodies
  • Analytics
  • Resources
  • About Ingentium

Clinical Trials

Information on Covid-19 clinical trials

  • Literature

  • Media

  • News

  • Clinical Trials Literature

    Establishing a human co-infection challenge study of Streptococcus pneumoniae (Spn) and live attenuated influenza vaccine (LAIV) in older healthy adults: Exploring Co-infection with Live Attenuated Influenza Vaccine and PneumococcuS in healthy oldEr adults (ECLIPSE), a UK-based single-centre, single-blind randomised controlled trial.

    October 14, 2026
    Publication date: Oct 12, 2026Open Access PDF Concepts Keywords Eclipse GERIATRIC MEDICINE Live IMMUNOLOGY Pneumoniae INFECTIOUS DISEASES Randomised Research Design Vaccine Semantics Type ...
  • Clinical Trials Literature

    When two worlds collide – the experiences of academic and Local Authority teams in implementing a cluster randomised control trial to test the impact of the MapMe tool on child healthy weight maintenance: a qualitative study.

    October 11, 2026
    Publication date: Oct 08, 2026Little is known about Local Authority (LA) teams’ involvement in and ...
  • Clinical Trials Literature

    Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.

    October 8, 2026
    Publication date: Oct 06, 2026Postacute sequelae of SARS-CoV-2 infection (long COVID) presents a therapeutic challenge, ...
  • Clinical Trials Literature

    Evaluating Creative Cognition as a Risk and Resilience Factor for Burnout in Pediatric Emergency Medicine.

    October 8, 2026
    Publication date: Oct 05, 2026Burnout is common among pediatric emergency medicine (PEM) physicians, but the ...
  • Clinical Trials Literature

    Temporary Cessation of DMARD Therapy and COVID-19 Supplemental Dose Vaccine Immunogenicity in Patients With Inflammatory Arthritis: The COVER Randomized Clinical Trial.

    October 8, 2026
    Publication date: Oct 05, 2026The COVID-19 pandemic disproportionately affected patients with autoimmune and rheumatic diseases. ...
  • Clinical Trials Literature

    Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients.

    October 8, 2026
    Publication date: Oct 05, 2026Older or medically unfit patients with diffuse large B-cell lymphoma (DLBCL) ...
  • Clinical Trials Literature

    Evaluating plasma ferritin and suPAR as treatable traits for critically ill patients with COVID-19 treated with anakinra: an exploratory analysis of the immune modulation domain of the REMAP-CAP randomised clinical trial.

    October 5, 2026October 5, 2026
    Publication date: Oct 01, 2026Identifying treatable traits in critically ill patients offers potential to enable ...
  • Clinical Trials Literature

    A Randomized Controlled Trial of Promoting First Relationships® Program With Parent-Child Dyads Reunified After Child Welfare System Separation.

    October 4, 2026
    Publication date: Oct 01, 2026Promoting First Relationships(R) (PFR) is a 10-session, evidence-based home-visiting program adapted ...
  • Clinical Trials News

    Monoclonal antibody for COVID meets safety endpoints in phase 3 trial

    October 4, 2026
    Publication date: Oct 02, 2026 Internal Server Error Internal Server Error Concepts Keywords Antibody Based Comirnaty Covid Group Hypersensitivity Invivyd Isr Monoclonal Participants Phase Reaction Safety Trial Vyd2311 Semantics Type Source ...
  • Clinical Trials Literature

    Real-world evaluation of 2023-2024 XBB.1.5 mRNA and protein-based COVID-19 vaccine reactogenicity from the randomized BEEHIVE trial.

    October 3, 2026
    Publication date: Dec 01, 2026The objective of this analysis was to assess reactogenicity profile differences ...
  • Clinical Trials Literature

    Adjudication of exacerbations in bronchiectasis using modified EMBARC criteria in the CLEAR Trial.

    October 2, 2026
    Publication date: Sep 01, 2026The EMBARC consensus criteria can be used to identify and categorise ...
  • Clinical Trials News

    VYD2311 Shows Superior Tolerability to mRNA COVID-19 Vaccine in Phase 3 Study

    October 2, 2026
    Publication date: Sep 30, 2026The study demonstrated that combining VYD2311 with an mRNA vaccine significantly ...
  • Clinical Trials Literature

    Process evaluation of a pharmacogenomic informed antidepressant prescribing intervention delivered in primary care: findings from the PRESIDE (PhaRmacogEnomicS in Depression) trial.

    October 1, 2026
    Publication date: Sep 28, 2026Major depressive disorder (MDD) impacts 300 million people globally, with most ...
  • Clinical Trials Literature

    Preliminary efficacy of a positive psychological intervention using virtual reality in older Korean immigrants: randomized controlled trial.

    October 1, 2026
    Publication date: Sep 27, 2026Our study examines the feasibility and preliminary efficacy of a randomized ...
  • Clinical Trials Literature

    Losartan with add-on spironolactone for severe COVID-19 in the intensive care unit: a randomized controlled trial.

    September 28, 2026
    Publication date: Sep 25, 2026The Coronavirus disease (COVID-19) pandemic caused significant mortality, predominantly among patients ...
  • Clinical Trials Literature

    Triage Administration of Ondansetron for Gastroenteritis in Children: A Randomized Controlled Trial.

    September 27, 2026
    Publication date: Sep 24, 2026Acute gastroenteritis is a leading cause of pediatric emergency department (ED) ...
  • Clinical Trials Literature

    Prophylactic vs Therapeutic Anticoagulation in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

    September 27, 2026
    Publication date: Sep 01, 2026Coagulopathy in the context of COVID-19 is a major threat due ...
  • Clinical Trials Literature

    Inhaled granulocyte-macrophage colony-stimulating factor (molgramostim) as host-directed therapy for pneumonia-related acute respiratory distress syndrome: a multicentre, randomised, placebo-controlled phase 2a trial (GI-HOPE).

    September 24, 2026
    Publication date: Sep 01, 2026Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances pulmonary host defence and promotes re-establishment ...
  • Clinical Trials News

    Boosting vaccination uptake using wastewater surveillance: a county-randomized controlled trial

    September 23, 2026
    Publication date: Sep 20, 2026Vaccine hesitancy remains a major public health challenge, highlighting the need ...
  • Clinical Trials Literature

    Burnout origins and psychological training needs of medical students and junior doctors: Mixed methods study.

    September 21, 2026
    Publication date: Sep 19, 2026Burnout continues to proliferate in medicine, with reductions in demands failing ...
  • Clinical Trials Literature

    A phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of sipavibart in healthy Japanese adults.

    September 21, 2026September 21, 2026
    Publication date: Sep 19, 2026Sipavibart, a recombinant human immunoglobulin G1-based monoclonal antibody against severe acute ...

Posts navigation

Older posts
ingentium

Ingentium Inc.
Email: support@ingentium.com
© 2016-2025 Ingentium, Inc.

Additional

  • Analytics
  • Contact Us
  • Terms of Service Agreement

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
Copyright © 2016-2026 All rights reserved.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}